Retatrutide is a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By activating these receptors, https://aprilsjux261140.59bloggers.com/36637931/retatrutide-a-promising-new-treatment-for-obesity